Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.48 |
| ▸ | APAF1 | O14727 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 5/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 5/20 | 0.47 |
| ▸ | POLB | P06746 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | DPP4 | P27487 | 7/20 | 0.47 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.46 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.46 |
| ▸ | HTT | P42858 | 3/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | PIM1 | P11309 | 2/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL32665192 | 0.94 | HSD17B10 (0.49) | ALDH1A1KDM4EAPAF1HPGDGAA | |
| SCHEMBL32664943 | 0.94 | ALDH1A1 (0.53) | ALDH1A1KDM4EAPAF1HPGDGAA | |
| SCHEMBL32665005 | 0.91 | ALDH1A1 (0.49) | ALDH1A1KDM4EAPAF1HPGDGAA | |
| SCHEMBL32665352 | 0.85 | MAPT (0.57) | ALDH1A1KDM4EAPAF1HPGDMAPT | |
| SCHEMBL32665526 | 0.85 | MAPT (0.57) | ALDH1A1KDM4EAPAF1HPGDMAPT | |
| SCHEMBL32664969 | 0.85 | HSD17B10 (0.63) | ALDH1A1KDM4EAPAF1HPGDGAA | |
| SCHEMBL32665284 | 0.83 | HSD17B10 (0.59) | ALDH1A1KDM4EAPAF1HPGDGAA | |
| SCHEMBL32665179 | 0.83 | HPGD (0.54) | ALDH1A1KDM4EAPAF1HPGDMAPT | |
| SCHEMBL32665055 | 0.83 | MAPT (0.54) | ALDH1A1KDM4EAPAF1HPGDMAPT | |
| SCHEMBL32664891 | 0.83 | KDM4E (0.53) | ALDH1A1KDM4EAPAF1HPGDGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260022124-A1 | THERAPEUTIC COMPOUNDS AND METHODS | UNIV MINNESOTA (US) | 2026-01-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260022124-A1 | THERAPEUTIC COMPOUNDS AND METHODS | NR5A1, CYP17A1, CNR1 | ALDH1A1 663/4885KDM4E 1972/4885APAF1 4398/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.